본문 바로가기
bar_progress

Text Size

Close

Developing IL-6 Inhibitor Treatment!! Starting Again!

Those who applied for < Seoyeon Top Metal (019770) > hit the daily limit in just 1 day! Achieved 31% profit!

Congratulations to everyone who applied for the free trial. ^^


※ For those who missed the “COVID-19 treatment” opportunity, no worries. We are going out strong once again.

※ Finally starting. Seoyeon Top Metal (019770) follow-up stock hits the daily limit on Tuesday. ※


▶▶ Starting big with the ‘daily limit’ on August 11 related to Samsung Electronics’ continuous rise! ‘ㅇㅇㅇㅇ’ related stocks! ▶ Apply for free trial ◀


Antibody-based therapeutic specialist company AbClon announced that it is expanding the indication of its autoimmune disease treatment AM201, which has a mechanism to inhibit IL-6, as a treatment for CRS experienced by severe COVID-19 patients!!

AM201 is a bispecific antibody therapeutic that inhibits IL-6, a disease protein known to cause autoimmune diseases. It is a new drug candidate discovered through AbClon’s bispecific antibody development platform AffiMab, and has a structural advantage that allows expansion of indications to various diseases accompanied by CRS caused by cytokine overproduction!!



▶▶ Heading straight ‘up’ on Tuesday. Moving fast, bispecific antibody therapeutic! Related beneficiary stocks! Don’t miss out [Apply now for ‘bispecific antibody therapeutic’ related stocks]


“The free trial was a turning point for me in stock trading. I was really curious how it was possible to make daily limit profits every day, but after seeing it in action, I was amazed. They provide stocks that hit the daily limit every day along with great information and education, so I am very satisfied. I am currently receiving VIP service and feel great knowing I can do stocks for life. Thank you.”

(VIP full-time investor Jang Han-cheol, age 57)


Now think of this as your last chance. If you miss this opportunity, you have to quit.

Exactly on “August 11” it will explode! Don’t miss out and regret it, just buy even with 100,000 KRW!



▶▶ “August 11 daily limit” offered only until today and then closed. [Receive ‘bispecific antibody therapeutic’ related stocks!] ▶ Receive stocks ◀


[AI recent daily limit hits]

*20.08.07 Seoyeon Top Metal (019770) daily limit hit!

*20.08.06 Hyosung ONB (097870) daily limit hit!

*20.08.05 DA Technology (196490) daily limit hit!

*20.08.04 Kainos Med (284620) daily limit hit!

*20.08.03 Access Bio (950130) daily limit hit!

*20.07.31 BioSmart (038460) daily limit hit!

*20.07.30 Simtek (222800) daily limit hit!

*20.07.29 Bitsro Tech (042370) daily limit hit!

*20.07.28 Hanmi Science (008930) daily limit hit!

*20.07.27 LTC (170920) daily limit hit!

*20.07.24 Kyungdong Pharmaceutical (011040) daily limit hit!

*20.07.23 LabGenomics (084650) daily limit hit!

*20.07.22 Ilsin Bio (068330) daily limit hit!

*20.07.21 Hwail Pharmaceutical (061250) daily limit hit!

*20.07.20 NewBotech (060260) daily limit hit!

*20.07.17 Euratech (048430) daily limit hit!

*20.07.16 Dong-A Hwasung (041930) daily limit hit!

*20.07.15 Barunson (018700) daily limit hit!

*20.07.14 VIDI (148140) daily limit hit!

*20.07.13 Sinopex (025320) daily limit hit!

*20.07.10 Jinyang Chemical (051630) daily limit hit!


▶▶ Only 30 spots available. “Tuesday daily limit”! ▶ Get it now ◀


※ First-come, first-served 30 spots closed! Both early and late rounds are finished. The hero of the last injury time winning goal ※


[Today’s stocks of interest]

#Wooridul Pharmaceutical #Anguk Pharm #Kolmar BNH #Bion #MedPacto


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top